logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • Peking Union Medical College Hospital: the results of the world's first phase 1 study of neural stem cell transplantation in the treatment of Parkinson's disease have been announced.
    2024-05-29
  • Shanghai discusses the innovation, regulation and market competition of cell therapy products.
    2024-05-28
  • An interpretation of Cell and Gene Therapy (CGT) in the Annual report on the Progress of New Drug Registration Clinical Trials in China (2023)
    2024-05-27
  • People's Daily: cell therapy promotes difficult and critical treatment to a new stage!
    2024-05-24
  • 10000+ cases confirmed that intravenous infusion of mesenchymal stem cells is safe!
    2024-05-23
Prev
... 31 32 33 34 35 ...
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号